Stern R M, Uijtdehaage S H, Muth E R, Koch K L
Department of Psychology, Penn State University, University Park 16802.
Aviat Space Environ Med. 1994 Jun;65(6):518-21.
The purpose of this study was to test the prophylactic effects of a single low dose of phenytoin on motion sickness. In this double-blind study, fasted male subjects who were susceptible to motion sickness were given either a 200-mg tablet of phenytoin (N = 19) or a placebo (N = 16). Electrogastrograms (EGG's) were recorded predrug, postdrug (4 h after ingestion of drug), before drum rotation, and during drum rotation. During testing, subjects were exposed to an optokinetic drum which was stationary for 8 min and which then rotated at 10 rpm for 16 min. The results showed that the phenytoin subjects had a lower mean subjective symptom score than the placebo group (5.8 vs. 7.1), but the difference was not significant. However, 6 of 16 placebo subjects requested early termination of drum rotation due to symptom severity, whereas only 2 of 19 phenytoin subjects terminated testing prematurely (X2 = 3.89, p < 0.05). The phenytoin group showed no increase in gastric tachyarrhythmia, the pattern of gastric myoelectric activity that usually accompanies nausea, during drum rotation, whereas tachyarrhythmia doubled for the placebo group. In conclusion, we have demonstrated that a single low dose of phenytoin prevents the development of gastric tachyarrhythmia and decreases the intensity of motion sickness symptoms.
本研究的目的是测试单次低剂量苯妥英对晕动病的预防作用。在这项双盲研究中,将易患晕动病的空腹男性受试者分为两组,一组给予200毫克苯妥英片剂(N = 19),另一组给予安慰剂(N = 16)。在给药前、给药后(服药后4小时)、鼓旋转前和鼓旋转期间记录胃电图(EGG)。在测试过程中,受试者暴露于一个视动鼓,该视动鼓静止8分钟,然后以10转/分钟的速度旋转16分钟。结果显示,苯妥英组的平均主观症状评分低于安慰剂组(5.8对7.1),但差异不显著。然而,16名安慰剂受试者中有6人因症状严重要求提前终止鼓旋转,而19名苯妥英受试者中只有2人提前终止测试(X2 = 3.89,p < 0.05)。苯妥英组在鼓旋转期间未出现胃性快速心律失常增加,胃性快速心律失常通常伴随恶心,而安慰剂组的快速心律失常增加了一倍。总之,我们已经证明,单次低剂量苯妥英可预防胃性快速心律失常的发生,并减轻晕动病症状的强度。